Xu B, Wang J, Yan B, Xu C, Yin Q, Yang D
Virus Evol. 2023; 7(2):veab071.
PMID: 36819972
PMC: 9927877.
DOI: 10.1093/ve/veab071.
Yi L, Zeng H, Zheng H, Peng J, Guo X, Liu L
Arch Virol. 2021; 166(6):1653-1659.
PMID: 33796884
DOI: 10.1007/s00705-021-05052-8.
Huang S, Cheng D, Wang J
J Biomed Sci. 2019; 26(1):81.
PMID: 31630680
PMC: 6802317.
DOI: 10.1186/s12929-019-0574-1.
Duong V, Mey C, Eloit M, Zhu H, Danet L, Huang Z
Emerg Microbes Infect. 2016; 5(9):e104.
PMID: 27651091
PMC: 5113052.
DOI: 10.1038/emi.2016.101.
Chang P, Chen S, Chen K
Int J Environ Res Public Health. 2016; 13(9.
PMID: 27618078
PMC: 5036723.
DOI: 10.3390/ijerph13090890.
Prediction of Protection against Asian Enterovirus 71 Outbreak Strains by Cross-neutralizing Capacity of Serum from Dutch Donors, The Netherlands.
van der Sanden S, Koen G, van Eijk H, Koekkoek S, de Jong M, Wolthers K
Emerg Infect Dis. 2016; 22(9):1562-9.
PMID: 27533024
PMC: 4994357.
DOI: 10.3201/eid2209.151579.
Cyclical Patterns of Hand, Foot and Mouth Disease Caused by Enterovirus A71 in Malaysia.
NikNadia N, Sam I, Rampal S, WanNorAmalina W, NurAtifah G, Verasahib K
PLoS Negl Trop Dis. 2016; 10(3):e0004562.
PMID: 27010319
PMC: 4806993.
DOI: 10.1371/journal.pntd.0004562.
Enterovirus 71 infection in children with hand, foot, and mouth disease in Shanghai, China: epidemiology, clinical feature and diagnosis.
Wang Y, Zou G, Xia A, Wang X, Cai J, Gao Q
Virol J. 2015; 12:83.
PMID: 26036928
PMC: 4464242.
DOI: 10.1186/s12985-015-0308-2.
Massive pulmonary hemorrhage in enterovirus 71-infected hand, foot, and mouth disease.
Lee D, Lee Y, Ahn J, Kim M, Kim J, Kim N
Korean J Pediatr. 2015; 58(3):112-5.
PMID: 25861335
PMC: 4388973.
DOI: 10.3345/kjp.2015.58.3.112.
Phylogenetic analysis of the VP1 gene of Enterovirus 71 in Guangzhou during the high occurrence period of 2008.
Yin Y, Ou Z, Xu Y, Zhou R, Xia H
Virus Genes. 2014; 48(3):538-42.
PMID: 24515837
DOI: 10.1007/s11262-014-1046-z.
Antigenic and genetic diversity of human enterovirus 71 from 2009 to 2012, Taiwan.
Huang Y, Lin T, Lin T, Wu H
PLoS One. 2013; 8(11):e80942.
PMID: 24348916
PMC: 3858369.
DOI: 10.1371/journal.pone.0080942.
Neutralizing activity induced by the attenuated coxsackievirus B3 Sabin3-like strain against CVB3 infection.
Jrad-Battikh N, Souii A, Oueslati L, Aouni M, Hober D, Gharbi J
Curr Microbiol. 2013; 68(4):503-9.
PMID: 24322405
DOI: 10.1007/s00284-013-0498-z.
Preclinical evaluation of the immunogenicity and safety of an inactivated enterovirus 71 candidate vaccine.
Hwa S, Lee Y, Brewoo J, Partidos C, Osorio J, Santangelo J
PLoS Negl Trop Dis. 2013; 7(11):e2538.
PMID: 24244774
PMC: 3820736.
DOI: 10.1371/journal.pntd.0002538.
Coxsackievirus A16: epidemiology, diagnosis, and vaccine.
Mao Q, Wang Y, Yao X, Bian L, Wu X, Xu M
Hum Vaccin Immunother. 2013; 10(2):360-7.
PMID: 24231751
PMC: 4185891.
DOI: 10.4161/hv.27087.
Human enterovirus 71 epidemics: what's next?.
Yip C, Lau S, Woo P, Yuen K
Emerg Health Threats J. 2013; 6:19780.
PMID: 24119538
PMC: 3772321.
DOI: 10.3402/ehtj.v6i0.19780.
Development and evaluation of a pseudovirus-luciferase assay for rapid and quantitative detection of neutralizing antibodies against enterovirus 71.
Wu X, Mao Q, Yao X, Chen P, Chen X, Shao J
PLoS One. 2013; 8(6):e64116.
PMID: 23755115
PMC: 3673970.
DOI: 10.1371/journal.pone.0064116.
Cross-reactive neutralizing antibody responses to enterovirus 71 infections in young children: implications for vaccine development.
Huang M, Chiang P, Chia M, Luo S, Chang L, Lin T
PLoS Negl Trop Dis. 2013; 7(2):e2067.
PMID: 23459633
PMC: 3573098.
DOI: 10.1371/journal.pntd.0002067.
Risk factors for neurologic complications of hand, foot and mouth disease in the Republic of Korea, 2009.
Kim S, Kim J, Kang J, Kim D, Kim K, Kim K
J Korean Med Sci. 2013; 28(1):120-7.
PMID: 23341722
PMC: 3546090.
DOI: 10.3346/jkms.2013.28.1.120.
Development of a Coxsackievirus A16 neutralization assay based on pseudoviruses for measurement of neutralizing antibody titer in human serum.
Jin J, Ma H, Xu L, An D, Sun S, Huang X
J Virol Methods. 2012; 187(2):362-7.
PMID: 23178532
PMC: 7112850.
DOI: 10.1016/j.jviromet.2012.11.014.
Challenges to licensure of enterovirus 71 vaccines.
Lee M, Tseng F, Wang J, Chi C, Chong P, Su I
PLoS Negl Trop Dis. 2012; 6(8):e1737.
PMID: 22953003
PMC: 3429393.
DOI: 10.1371/journal.pntd.0001737.